A look at CART-T administration - Discussing the challenges and opportunities institutions face in administering CAR-T

Executed on:Apr 7, 2025 4:30 PM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: StanfordDistinguished hematologist and Professor of Medicine at Stanford University, where he served as Chief of the Division of Blood and Marrow Transplantation.
Administers 200 CAR T cell therapies per year, increasing at 10-15% per year.
Research focuses on cellular immunology, particularly graft-versus-host and graft-versus-tumor reactions, and has authored over 265 peer reviewed publications.

Interview Goal

This call will explore the adoption of CAR-T cell therapies, analyzing the challenges involved in their administration and the reasons why institutions choose to administer CAR T cell therapies

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.